Roivant Sciences (ROIV) Total Debt (2021 - 2024)

Roivant Sciences has reported Total Debt for 4 years, with the latest figure at $203.5 million in Q2 2024.

• For the quarter ending Q2 2024, Total Debt rose 154.9% year-over-year to $203.5 million; the trailing twelve-month figure through Jun 2024 stood at $203.5 million (up 154.9% YoY), and the FY2024 full-year result was $49.5 million, down 75.34% from the prior year.
• Total Debt for Q2 2024 stood at $203.5 million, up from $49.5 million in the prior quarter.
• The five-year high for Total Debt was $217.7 million in Q4 2023, with the low at $32.6 million in Q1 2022.
• Historically, Total Debt has averaged $138.0 million across 4 years, with a median of $178.3 million in 2021.
• Annual changes were most pronounced in 2022 — Total Debt sank 82.13% — and 2023, when it soared 515.19%.
• Roivant Sciences' Total Debt stood at $204.0 million in 2021, then slumped by 64.73% to $72.0 million in 2022, then jumped by 202.48% to $217.7 million in 2023, then declined by 6.51% to $203.5 million in 2024.
• The last three Total Debt figures came in at $203.5 million (Q2 2024), $49.5 million (Q1 2024), and $217.7 million (Q4 2023), per Business Quant data.